期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

BRAF突变对甲状腺乳头状癌摄碘相关蛋白表达影响及相关分子靶向治疗 被引量：7

Recent advances in molecular targeted therapy and expression of iodine uptake relative protein in papillary thyroid carcinoma with BRAFv mutation
原文传递
导出
摘要 B型RAF基因（BRAF）是近年来甲状腺癌中研究最热的基因之一，其突变与甲状腺乳头状癌的发生发展及治疗、预后有着重要的联系，本文就BRAF。突变对乳头状甲状腺癌细胞中摄碘相关蛋白碘钠同向转运体、促甲状腺激素受体表达的影响及其相关的分子靶向治疗进行综述，并对其在乳头状甲状腺癌治疗中的临床价值进行评述、展望。 Type-B RAF （BRAF） gene is one of the most popular genes of thyroid carcinoma in recent studies, and its mutation has significant relationships with the occurrence, development, treatment, and prognosis of papillary thyroid carcinoma（ PTC ）. The influence of BRAFmutation on the expression of iodine uptake relative proteins in PTC cells and the value of molecular targeted therapy with BRAF Einhibitors in the clinical treatment of PTC in the future were summarized in this review.
作者 杜秋丽 黄韬
机构地区 华中科技大学同济医学院附属协和医院乳腺甲状腺外科
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2013年第7期624-626,共3页 Chinese Journal of Endocrinology and Metabolism
关键词 BRAF 甲状腺乳头状癌 钠碘同向转运体 促甲状腺激素受体 分子靶向治疗 BRAF Papillary thyroid cancer Sodium iodide symporter Thyroid stimulating hormonereceptor Molecular targeted therapy
分类号 R736.1 [医药卫生—肿瘤]
  • 相关文献

参考文献25

  • 1陈家伦.甲状腺结节与分化型甲状腺癌.见:陆再英,钟南山,主编.内科学,第7版.北京:人民卫生出版社,2008,731.
  • 2Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin, 2009,59 :225-249.
  • 3Bela B, Sarka D, Vlasta S, et al. Thyroid tumors-molecular genetic causes and choices for target therapy. Cas Lek Cesk, 2012,151: 123- 127.
  • 4Durante C, Puxeddu E, Ferretti E, et al. BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism. J Clin Endocrinol Metab, 2007,92:2840-2843.
  • 5Shuntaro I, Mikiharu F, Y oshto U, et al. B-raf, a new member of the raf family is activated by DNA rearrangement. Mol Cell Bioi, 1988,8: 2651-2654.
  • 6Norisato M, Jeffrey AK, Shin M, et al. Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells. Cancer Res, 2005,65:2465-2473.
  • 7Sun WK, Ji 1L, Jong-Won K, et al. BRAFV600E mutation analysis in fine-needle aspiration cytology specimens for evaluation of thyroid nodule: a large series in a BRAFV600E-prevalent population. J Clin Endocrinol Metab, 2010 ,95 :3693-3700.
  • 8Oler G, Cerutti M. High prevalence of BRAF mutation in a Brazilian cohort of patients with sporadic papillary thyroid carcinomas: correlation with more aggressive phenotype and decreased expression of iodide-metabolizing genes. Cancer, 2009,115 :972-980.
  • 9Garcilaso RE, Irene R, Antonio DV , et al. The BRAFV600E oncogene induces transforming growth factor 13 secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer. Cancer Res, 2009 ,69 : 8317 -8325.
  • 10吕红彬,闫乃红,罗清礼,夏庆杰,曹桂群,张发强.促甲状腺素受体在BALB/c小鼠主要组织和器官的分布及其意义[J].解剖学杂志,2006,29(5):557-560. 被引量：5

二级参考文献23

  • 1张一帆,李彪,赵龙,尤蓓,尹桂芝,贾世海,朱承谟.杆状病毒介导NIS基因放射治疗甲状腺癌的实验研究[J].中华核医学杂志,2004,24(5):264-267. 被引量：6
  • 2Park HJ,Kim JY,Park KY,et al.Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas.Thyroid,2000,10:211-217.
  • 3Maenhaut C,Brabant G,Vassart G,etal.In vitro and in vivo regulation of thyrotropin receptor mRNA levels in dog and human thyroid cells.J Biol Chem,1992,267:3000-3007.
  • 4Coelho SM,Carvalho DP,Vaisman M,et al.New perspectives on the treatment of differentiated thyroid cancer.Arq Bras Endocrinol Metabol,2007,51:612-624.
  • 5Weiss S J,Philp NJ,Grollman EF.Iodide transport in a continuous line of cultured cells from rat thyroid.Endocrinology,1984,114:1090-1098.
  • 6Derwahl M,Kuemmel M,Goretzki P,et al.Expression of the human TSH receptor in a human thyroid carcinoma cell line that lacks an endogenous TSH receptor:growth inhibition by cAMP.Biochem Biophys Res Commun,1993,191:1131-1138.
  • 7Hoelting T,Duh QY,Clark OH,et al.Transfection of follicular thyroid gland carcinoma cells with human TSH receptor changes growth,invasion and adhesion.Langenbecks Arch Chir Suppl Kongressbd,1998,115(Suppl Ⅰ):281-284.
  • 8Parmentier M,Libert F,Maenhaut C,et al.Molecular cloning of the thyrotropin receptor.Science,1989,246:1620-1622.
  • 9Hoffmann S,Maschuw K,Hassan I,et al.Functional thyrotropin receptor attenuates malignant phenotype of follicular thyroid cancer cells.Endocrine,2006,30:129-138.
  • 10Costagliola S,Rodien P,Many MC,et al.Genetic immunization against the human thyrotropin receptor causes thyroiditis and allows production of monoclonal antibodies recongnizing the native receptor.J Immunol,1998,160(3):1458-1465.

共引文献5

同被引文献75

  • 1周晓明,张国昌,李锋,赵瑾,李洪安,蒋金芳.甲状腺癌中ret/ptc癌基因表达的研究[J].广东药学院学报,2005,21(3):323-326. 被引量：3
  • 2陈一峰,连云宗,曾志雄,庄建良.彩色多普勒超声检测乳头状甲状腺癌血流及病理微血管密度与颈部淋巴结转移的关系[J].中国现代医学杂志,2007,17(18):2251-2254. 被引量：22
  • 3高云朝,杨亚东,陆汉魁.血清甲状腺球蛋白及其自身抗体在化学发光免疫分析时的相互影响[J].检验医学,2007,22(5):558-560. 被引量：10
  • 4Popoveniuc G, Jonklaas J. Thyroid nodules. Med Clin North Am, 2012,96:324-329.
  • 5Gharib H, Papini E, Paschke R, et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules : executive summary of recommendations. J Endocrinol Invest, 2010,33 (5 Suppl) :51-56.
  • 6Bomeli SR, LeBeau SO, Ferris RL. Evaluation of a thyroid nodule. Otolaryngol Clin North Am, 2010,43:229-238.
  • 7Xing M. BRAF mutation in thyroid cancer. Endocr Relat Cancer, 2005,12:245-262.
  • 8Alexander EK, Kennedy GC, Baloch ZW, et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med, 2012,367:705-715.
  • 9Bongiovanni M, Krane JF, Cibas ES, et al. The atypical thyroid fine- needle aspiration : past, present, and future. Cancer Cytopathol, 2012,120:73-86.
  • 10Chen YT, Kitabayashi N, Zhou XK, et al. MicroRNA analysis as a potential diagnostic tool for papillary thyrold carcinoma. Mod Pathol, 2008,21 : 1139-1146.

引证文献7

二级引证文献31

中华内分泌代谢杂志
2013年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部